tradingkey.logo

Galmed Pharmaceuticals Ltd

GLMD
View Detailed Chart

1.550USD

0.0000.00%
Close 08/01, 16:00ETQuotes delayed by 15 min
3.50MMarket Cap
LossP/E TTM

Galmed Pharmaceuticals Ltd

1.550

0.0000.00%
Intraday
1m
30m
1h
D
W
M
D

Today

-6.06%

5 Days

-22.11%

1 Month

-15.07%

6 Months

-42.59%

Year to Date

-51.41%

1 Year

-57.62%

View Detailed Chart

Agency Rating

Analyst Rating

Based on 1 analysts
HOLD
Current Rating
0.000
Target Price
0.00%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

552
Total
5
Median
6
Average
Company name
Ratings
Analysts
Galmed Pharmaceuticals Ltd
GLMD
1
CRISPR Therapeutics AG
CRSP
29
Intellia Therapeutics Inc
NTLA
28
Ionis Pharmaceuticals Inc
IONS
27
Exact Sciences Corp
EXAS
27
IQVIA Holdings Inc
IQV
25
1
2
3
...
111

Indicators

The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

1m
15m
30m
1h
D
W
M
1m
15m
30m
D
Sell
Sell(8)
Neutral(2)
Buy(0)
Indicators
Sell(2)
Neutral(2)
Buy(0)
Indicators
Value
Direction
MACD(12,26,9)
-0.122
Neutral
RSI(14)
38.582
Neutral
STOCH(KDJ)(9,3,3)
12.502
Oversold
ATR(14)
0.206
High Vlolatility
CCI(14)
-158.505
Sell
Williams %R
91.860
Oversold
TRIX(12,20)
-0.014
Sell
StochRSI(14)
0.000
Oversold
Moving Average
Sell(6)
Neutral(0)
Buy(0)
Indicators
Value
Direction
MA5
1.714
Sell
MA10
1.800
Sell
MA20
1.928
Sell
MA50
1.746
Sell
MA100
1.642
Sell
MA200
2.299
Sell

News

More news coming soon, stay tuned...

Financial Indicators

EPS

No Data

Total revenue

No Data

Company

Galmed Pharmaceuticals is a Israeli-based clinical-stage biopharmaceutical company.The activiti of the Company is focused on the development therapy for treating liver diseases. Arachmol, the main product of Galmed Pharmaceuticals, is a liver-targeted stearoyl-coenzyme A desaturase1 used in oral therapy for the treatment of NASH (Non-alcoholic Steatohepatitis).
Ticker SymbolGLMD
CompanyGalmed Pharmaceuticals Ltd
CEOMr. Allen Baharaff
Websitehttps://www.galmedpharma.com
KeyAI